3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
542
Triple Negative Breast Neoplasms
86
Neoplasms
18
Colorectal Neoplasms
18
Lung Neoplasms
16
Neoplasm Metastasis
15
Advanced Breast Cancer
15
Prostatic Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Motor Activity
12
Breast Cancer Lymphedema
12
HER2-positive Breast Cancer
11
Uterine Cervical Neoplasms
10
Stomach Neoplasms
10
Ovarian Neoplasms
10
Endometrial Neoplasms
10
Carcinoma, Intraductal, Noninfiltrating
10
Anxiety Disorders
10
Depression
8
Brain Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Pain, Postoperative
6
Pain
6
Melanoma
6
Lymphedema
6
Head and Neck Neoplasms
6
Colonic Neoplasms
6
Cardiotoxicity
6
Pancreatic Neoplasms
5
Liver Neoplasms
5
Interventions
lenvatinib
1
camrelizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced Triple Negative Breast Cancer
×
Breast
×
Clear all
NCT06849492
2025-02-27
SHIFT-001
Fudan University
Phase 2
Not yet recruiting
120 enrolled